Literature DB >> 17721013

Stroke complicating percutaneous coronary intervention in patients with acute myocardial infarction.

Akio Kawamura1, Daniel A Lombardi, Matthew E Tilem, David E Gossman, Thomas C Piemonte, Richard W Nesto.   

Abstract

BACKGROUND: Stroke associated with percutaneous coronary intervention (PCI) is a tragic complication. Despite advances in the practice of PCI, the incidence of stroke complicating PCI has not changed over the decades. The objective of the present study was to evaluate incidence and correlates of stroke occurring in patients with myocardial infarction (MI) undergoing PCI. METHODS AND
RESULTS: Stroke was defined as the presence of any new focal neurological deficit lasting > or =24 h that occurred anytime during or after PCI until discharge. In 2,281 consecutive patients with PCIs for non-ST-elevation MI, or ST-elevation MI (STEMI), 20 strokes were identified (0.88%). Strokes were ischemic in 95%. On multivariate analyses, ejection fraction < or =30% (odds ratio =4.3, p=0.003) was the only independent predictor for stroke. In patients who developed stroke within 24 h of PCI, PCI of vein grafts was more frequent, and use of glycoprotein IIb/IIIa inhibitor was less frequent. Those patients tended to present late in the course of MI. Stroke found more than 24 h after PCI was related to diabetes, higher serum creatinine, lower ejection fraction, anterior wall STEMI and emergency use of intra-aortic balloon pumps.
CONCLUSIONS: Low ejection fraction was the only independent predictor for stroke, but risk factors for periprocedural stroke are different from those of stroke occurring more than 24 h after PCI. Upstream use of glycoprotein IIb/IIIa inhibitor might decrease the risk of periprocedural stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721013     DOI: 10.1253/circj.71.1370

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  Temporal trends in percutaneous coronary intervention--associated acute cerebrovascular accident (from the 1998 to 2008 Nationwide Inpatient Sample Database).

Authors:  Anupama Shivaraju; Changhong Yu; Michael W Kattan; Hui Xie; Adhir R Shroff; Mladen I Vidovich
Journal:  Am J Cardiol       Date:  2014-05-06       Impact factor: 2.778

Review 2.  Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first?

Authors:  Leonard L L Yeo; Tommy Andersson; Kong Wan Yee; Benjamin Y Q Tan; Prakash Paliwal; Anil Gopinathan; Mahendran Nadarajah; Eric Ting; Hock L Teoh; Robin Cherian; Erik Lundström; Edgar L W Tay; Vijay K Sharma
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

3.  Incidence and Long-Term Outcomes of Stroke in Patients Presenting With ST-Segment Elevation-Myocardial Infarction: Insights From the Midwest STEMI Consortium.

Authors:  Michael Megaly; Mehmet Yildiz; Edward Tannenbaum; Brynn Okeson; Marshall W Dworak; Ross Garberich; Scott Sharkey; Frank Aguirre; Mark Tannenbaum; Timothy D Smith; Timothy D Henry; Santiago Garcia
Journal:  J Am Heart Assoc       Date:  2021-11-24       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.